Your only pleural mesothelioma news source!
Click on each item to read full story.
|
Chemotherapy Does Not Improve Treatment For Mesothelioma (Medical News Today)
read story
For mesothelioma patients, the addition of chemotherapy to the usualactive symptom control (ASC) does not appear to improve survival orquality of life, according to an article released on May 16, 2008 in TheLancet. Malignant pleural mesothelioma (MPM) is cancer of the mesothelium, theprotective layer that covers the lungs.
|
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (MedicineNet.com)
read story
Title: Chemo for Mesothelioma Offers Limited Survival Benefits Category: Health News Created: 5/16/2008 2:00:00 AM Last Editorial Review: 5/16/2008 |
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (HealthDay via Yahoo! News)
read story
THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not appear to improve either survival or quality of life. |
| |
News Based On Abstracts Or Poster Presentations At The Annual Meeting Of The American Society Of Clinical Oncology ... (Medical News Today)
read story
The annual meeting of the American Society of Clinical Oncology (ASCO) to be held in Chicago, Illinois, May 30 - June 3, 2008.Study Tracks a Biomarker for Early Detection of Malignant Pleural MesotheliomaAbstract # 11074: Plasma osteopontin is an early detection and prognostic marker in malignant pleural mesotheliomaNYU Cancer Institute's Harvey Pass, M.D. |
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (HealthCentral.com)
read story
Copyright © 2008 ScoutNews LLC. All rights reserved. THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not appear to improve either survival or quality of life. |
| |
Asbestos-Induced Lung Cancer Patients Do Not Appear To Benefit From Chemotherapy, UK (Medical News Today)
read story
Adding chemotherapy to established methods of symptom management does not appear to enhance the quality of life or survival of patients suffering from an asbestos-induced form of lung cancer called malignant plural mesothelioma (MPM). |
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (KOLD News 13 Tuscon)
read story
THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not... |
| |
Chemo for Mesothelioma Offers Limited Survival Benefits (Health Scout)
read story
Therapy does not appear to help quality of life for lung cancer linked to asbestos. |
| |
NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO (EurekAlert!)
read story
The following news tips are based on abstracts or poster presentations at the annual meeting of the American Society of Clinical Oncology (ASCO) to be held in Chicago, Illinois, May 30 – June 3, 2008. |
| |
Rosetta Genomics To Present Multiple Posters At The 44th Annual Meeting Of The American Society Of Clinical Oncology ... (Medical News Today)
read story
Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced that it will present multiple posters at the upcoming ASCO annual meeting in Chicago. The company also has three publication only abstracts available on ASCO's website. The event will take place from May 30 to June 3 at the McCormick Place, Chicago, Illinois. |
| |